LMORX
Price
$45.27
Change
+$0.23 (+0.51%)
Updated
Sep 26 closing price
Net Assets
1.79B
VIMAX
Price
$362.22
Change
+$3.99 (+1.11%)
Updated
Sep 26 closing price
Net Assets
199.16B
Interact to see
Advertisement

LMORX vs VIMAX

Header iconLMORX vs VIMAX Comparison
Open Charts LMORX vs VIMAXBanner chart's image
Patient Opportunity R
Price$45.27
Change+$0.23 (+0.51%)
VolumeN/A
Net Assets1.79B
Vanguard Mid Cap Index Admiral
Price$362.22
Change+$3.99 (+1.11%)
VolumeN/A
Net Assets199.16B
LMORX vs VIMAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LMORX vs. VIMAX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMORX is a Hold and VIMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 199B vs. LMORX (1.79B). VIMAX pays higher dividends than LMORX: VIMAX (1.47) vs LMORX (0.00). LMORX was incepted earlier than VIMAX: LMORX (19 years) vs VIMAX (24 years). LMORX (2.02) is less costly to investors than VIMAX (0.05). LMORX is a more actively managed with annual turnover of: 31.00 vs. VIMAX (16.00). LMORX has a lower initial minimum investment than VIMAX: LMORX (0) vs VIMAX (3000). LMORX annual gain was more profitable for investors over the last year : 30.76 vs. VIMAX (11.60). VIMAX return over 5 years is better than : 70.93 vs. LMORX (60.36).
LMORXVIMAXLMORX / VIMAX
Total Expense Ratio2.010.054,020%
Annual Report Gross Expense Ratio2.020.054,040%
Fund Existence19 years24 years-
Gain YTD20.27110.884186%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.79B199B1%
Annual Yield % from dividends0.001.47-
Returns for 1 year30.7611.60265%
Returns for 3 years90.2155.85162%
Returns for 5 years60.3670.9385%
Returns for 10 years149.28161.0493%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UNM78.261.56
+2.03%
Unum Group
APGE38.220.70
+1.87%
Apogee Therapeutics
LIDR2.36-0.03
-1.26%
AEye
ADV1.56-0.05
-3.11%
Advantage Solutions
CPHI1.87-0.08
-3.90%
China Pharma Holdings Inc